Hein Park Capital Management LP In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Hein Park Capital Management LP reported 2 stock positions worth $122.9 million . Its top holding was Diebold Nixdorf (DBD) at 85.7% of the portfolio, followed by Bausch Health Cos (BHC, 14.3% ). Compared with Q4 2023, it added to 1 and reduced 1. The biggest buy was Bausch Health Cos (BHC, shares +57% ) and the biggest sale Diebold Nixdorf (DBD, shares −6% ).
Location New York, NY
CIK 0001826937
Portfolio Value $122.9M (Q1 2024) Holdings 2 stocks · $122.9M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2023 DBD Diebold Nixdorf Inc. 85.73% 3,060,198 $105.4M Reduce -6.1% BHC Bausch Health Cos Inc. 14.27% 1,653,579 $17.5M Add +57.0%
Other holdings (2): bonds, preferreds, convertibles and warrants · $19.4M (not counted above) Total filed on the 13F, all lines: $142.4M.
Portfolio Sells Q4 2023 → Q1 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▲ DBD Diebold Nixdorf Inc. Reduce -6.1% 85.73% −6.05
Portfolio Buys Q4 2023 → Q1 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▼ BHC Bausch Health Cos Inc. Add +57.0% 14.27% +6.05
Options Activity Q4 2023 → Q1 2024 Security Type Change vs Q4 2023 Underlying Shares Value ▼ SPY SS SPDR S&P 500 ETF Trust-US put Sold out 500,000 $237.7Mbefore exit LYV Live Nation Entertainment Inc. put Sold out 500,000 $46.8Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 2 $50.2M CZR, SGRY Q1 2026 1 $61.3M CZR Q4 2025 1 $54.3M CZR Q3 2025 2 $85.5M CZR, DBD Q2 2025 2 $136.1M DBD, CZR Q1 2025 3 $181.7M DBD, CZR, SGRY Q4 2024 3 $126.6M DBD, SGRY, BHC Q3 2024 2 $136.9M DBD, BHC Q2 2024 2 $123.7M DBD, BHC Q1 2024 2 $122.9M DBD, BHC